Sefah Israel Abebrese, Mensah Michael, Hutton-Nyameaye Araba Ata, Sarkodie Emmanuel, Meyer Johanna C, Godman Brian, Bangalee Varsha
University of Health and Allied Sciences, Ho, Ghana.
Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
PLoS One. 2025 Jan 24;20(1):e0312094. doi: 10.1371/journal.pone.0312094. eCollection 2025.
Diabetes mellitus (DM) is a global health problem. Adherence to intensive insulin therapy is necessary to achieve better glycemic control in types 1 and 2 DM. This study aimed to evaluate the extent of adherence to insulin therapy, its predictors and to identify barriers to its adherence.
This was a cross-sectional survey among adult (≥18 years) diabetic patients who are currently using insulin, either alone or in combination with an oral antidiabetic regimen, and seeking primary care at Kwame Nkrumah University of Science and Technology Hospital in Ghana. A total of one hundred and eight-six patients were conveniently sampled, and interviewed. Insulin adherence was determined using the Medication Adherence Reporting Scale-5. Descriptive statistics, a chi-square test of independence, and a multiple logistic regression analysis were performed using STATA version 14 (StataCorp, TX USA).
The majority of the patients interviewed were over 60 years (40.32%); female (61.83%); married (68.82%); and had completed secondary education (48.39%). 67.20% of the patients were adherent to insulin therapy. Adherence level was associated with age (p = 0.020), marital status (p = 0.001), employment status (p = 0.012), type of DM (p<0.001), regular follow-up (p = 0.007) and comorbidities (p = 0.002) and was only predicted by the type of DM (aOR = 14.82 C.I 1.34-163.50, p-value = 0.028).
Adherence to insulin therapy among our study population was suboptimal, which is a concern considering the associated increased risk of complications. Adherence assessment and counselling by healthcare professionals to address barriers to poor adherence must be continually undertaken to achieve optimal glycemic control.
Continuous adherence assessment and counselling must be offered to all diabetes mellitus patients on insulin therapy as part of their ambulatory care to help improve outcomes.Using the Medication Adherence Reporting Scale-5 to determine patient adherence levels is an easy-to-use and an inexpensive method; however, it should be used with caution due to the potential for misclassification.Efforts must be made to provide appropriate strategies to deal with barriers to insulin adherence at ambulatory care clinics as part of the individualized comprehensive diabetic care to reduce diabetic complications.
糖尿病是一个全球性的健康问题。对于1型和2型糖尿病患者,坚持强化胰岛素治疗对于实现更好的血糖控制是必要的。本研究旨在评估胰岛素治疗的依从程度、其预测因素,并确定依从性的障碍。
这是一项横断面调查,对象为成年(≥18岁)糖尿病患者,他们目前正在使用胰岛素,单独使用或与口服抗糖尿病方案联合使用,并在加纳夸梅·恩克鲁玛科技大学医院寻求初级护理。总共方便抽取了186名患者并进行访谈。使用药物依从性报告量表-5来确定胰岛素依从性。使用STATA 14版(美国德克萨斯州StataCorp公司)进行描述性统计、独立性卡方检验和多元逻辑回归分析。
接受访谈的大多数患者年龄超过60岁(40.32%);女性(61.83%);已婚(68.82%);并且完成了中等教育(48.39%)。67.20%的患者坚持胰岛素治疗。依从水平与年龄(p = 0.020)、婚姻状况(p = 0.001)、就业状况(p = 0.012)、糖尿病类型(p<0.001)、定期随访(p = 0.007)和合并症(p = 0.002)相关,并且仅由糖尿病类型预测(调整后比值比 = 14.82,置信区间1.34 - 163.